Tags |
|
|
Links |
|
|
Digg It - CEO's are Linked to Their Supply Chains
CEO’s are linking strategically into their supply chains. Their supply chain is the best place to make the most of CEO effectiveness in product needs, real savings opportunities, ultimate customer satisfaction and therefore shareholder value. New technologies, changes in asset provider capacities, tra
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
nsportation management options and difficulty in organizations overcoming paradigms are making the CEO’s involvement in their supply chain success critical.
The supply chain is the movement of raw materials and finished products, impacting purchasing practices, manufacturing efficiencies, inventory car
The supply chain is the movement of raw materials and finished products, impacting purchasing practices, manufacturing efficiencies, inventory car
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
rying costs, departmental optimization, product value differentiation, business growth and ultimately marketplace viability. Most businesses underestimate the true costs, much less opportunities of their supply chain.
CEO’s who rely on the silo functionality of their managers often do not see the sub
CEO’s who rely on the silo functionality of their managers often do not see the sub
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
optimization of internal departments. Competition for scarce resources, missed opportunities in controlling costs, dynamic process efficiencies available in the supply chain, new value add technologies, leveraging greater buying power, impact of old relationships with inefficient transportation provide
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
s, passing on higher costs with declining deliverable values, are just a few issues where the vision of the CEO is needed. Instead of managing the supply chain as a departmental function, real savings and value await those who incorporate leading edge processes across all departmental functions to optim
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
ize spend, value, growth and profitability.
New transportation management companies are emerging with business models that address supply chain efficiencies on contingency basis. Loaded with leading edge technology, dedicated account management teams to monitor deliverable values and unparalleled abil
New transportation management companies are emerging with business models that address supply chain efficiencies on contingency basis. Loaded with leading edge technology, dedicated account management teams to monitor deliverable values and unparalleled abil
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
ity to leverage spend savings, these new transportation management companies are growing at triple digit percentages. Unfortunately, either past experiences with unfocused providers or relying on single departmental management has limited companies from increasing sales and improving their bottom lines
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
with their supply chain.
Purchasing managers and logistics managers are unable to leverage savings beyond current company scale nor able to engineer or afford the technology for real time supply chain visibility on their own. The silos of functionality in business are often good at meeting their metr
Purchasing managers and logistics managers are unable to leverage savings beyond current company scale nor able to engineer or afford the technology for real time supply chain visibility on their own. The silos of functionality in business are often good at meeting their metr
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
cs but unable to create new approaches to incorporating supply chain opportunities across all departments. Only the leadership of the CEO can create the vision of engaging new resources and technologies that can improve the entire organization’s deliverable results.
The complexity of transportation pr
The complexity of transportation pr
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
ovider choices, varying market reach and multiple customer needs, call for a new approach in using a focused transportation management company to optimize the value of their unique supply chain. To only require the best providers with the lowest prices set up purchasing and logistics departments to bid
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
, renegotiate or partnership for the best of a mediocre bunch of commodity providers, leaving value and money on the table.
Without losing control of day to day provider selection, smart companies are outsourcing the negotiations to a new class of transportation management company that can guarantee sp
Without losing control of day to day provider selection, smart companies are outsourcing the negotiations to a new class of transportation management company that can guarantee sp
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
end savings, superior transit deliverables, real time visibility of supply chain across all department functions and provide dedicated account management teams accountable to unique departmental needs. Not engaging your potential leaves the company vulnerable to competitors who recognize the supply cha
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
n can be leveraged to add value, grow business and improve net profits.
The clear trend in supply chain management is this new breed of focused providers who can leverage greater spend savings, develop customized, scalable real time technologies across all functions and add dedicated account teams to m
The clear trend in supply chain management is this new breed of focused providers who can leverage greater spend savings, develop customized, scalable real time technologies across all functions and add dedicated account teams to m
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
anage the transportation providers. Portfolios loaded mid and large size corporations, with best practices and industry specific case studies, these transportation management companies can cut through the jargon of supply chain applications and deliver measurable results. The CEO must create the visio
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
n of new possibilities, facilitating his teams to achieve greater savings & value, with more control over their supply chain, real deliverable results for employee job security and shareholder value.
Old asset players in transportation are either one dimensional in capability or try to leverage the ill
Old asset players in transportation are either one dimensional in capability or try to leverage the ill
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
usion of value with their own spin on limited capabilities and risk adverse thinking. The emerging transportation management companies are lean, bureaucracy free, accountable to you and at no cost as they contingency based. Despite what asset transportation providers present in poor yields, inflated f
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
el costs, labor and health care concerns (like manufacturers/distributors do not have the same challenges?), the right transportation management company can still create guaranteed savings of at least 10% of current spend, bring value add technology for supply chain visibility as well as dedicated 24/7
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
account service teams to inspired manufacturers/distributors.
The complexity of asset transportation provider systems, varying costs by product/lane, limited technology and no doubt unsatisfactory past experiences, have stymied manufacturers/distributors on how to proceed in maximizing supply chain eff
The complexity of asset transportation provider systems, varying costs by product/lane, limited technology and no doubt unsatisfactory past experiences, have stymied manufacturers/distributors on how to proceed in maximizing supply chain eff
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
iciencies. Only this new class of transportation management companies is capable of delivering the right provider solution, for each link of your supply chain, for the best available value & cost, with total visibility and accountability.
While there are many opportunities and duties for today’s CEO,
While there are many opportunities and duties for today’s CEO,
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
no other area of their business will bring the greatest value return for their time investment than their supply chain. Reaching out to these unique, no cost, and no risk, transportation management providers will certainly be worth their time as employees, customers and shareholders will no doubt agree
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.diggit.org.ua/article/20737/diggit-CEOs-are-Linked-to-Their-Supply-Chains.html">CEO's are Linked to Their Supply Chains</a>
BB link (for phorums):
[url=http://www.diggit.org.ua/article/20737/diggit-CEOs-are-Linked-to-Their-Supply-Chains.html]CEO's are Linked to Their Supply Chains[/url]
Related Articles:
Implementation of the Purchase Process: Partnership or Supplier
Going Public: How Long Does it Take?
Prototypes, The Granddaddy Of All Products
Bookmark it:
|